Ingredient record · Diuretic for blood pressure
Hydrochlorothiazide: bans, restrictions and failed batches in India
Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026
5 entries containing Hydrochlorothiazide are on India's banned-drugs list, and 4 are banned today. 12 batches of medicines containing Hydrochlorothiazide failed a government lab test between February 2022 and July 2026, from 10 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
Is it banned? Our answer pages
On the banned-drugs list
Hydrochlorothiazide on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Propranolol + Hydrochlorothiazide + DihydralazineFixed-dose combination · cardiac | Banned | S.O. 248(E) | 11 January 2019 | Other orders | One of 80 FDCs prohibited vide S.O. 180(E)-259(E) dated 11.01.2019 (CDSCO letter 22.01.2019). In force per CDSCO list as on 22.11.2021. |
| Telmisartan + Ramipril + HydrochlorothiazideFixed-dose combination · cardiac | Banned | S.O. 252(E) | 11 January 2019 | Other orders | One of 80 FDCs prohibited vide S.O. 180(E)-259(E) dated 11.01.2019 (CDSCO letter 22.01.2019). In force per CDSCO list as on 22.11.2021. |
| Hydrochlorothiazide + Ramipril + Losartan PotassiumFixed-dose combination · cardiac | Banned | S.O. 259(E) | 11 January 2019 | Other orders | One of 80 FDCs prohibited vide S.O. 180(E)-259(E) dated 11.01.2019 (CDSCO letter 22.01.2019). In force per CDSCO list as on 22.11.2021. |
| Olmesartan + Hydrochlorothiazide + ChlorthalidoneFixed-dose combination · cardiac | Banned | S.O. 4455(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Olmesartan + Hydrochlorothiazide + ChlorthalidoneFixed-dose combination · cardiac | Quashed | S.O. 787(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Telmisartan Hydrochlorothiazide | 10 | 8 | Jul 2026 |
| Telvas H / | 1 | 1 | Mar 2025 |
| Losacon H | 1 | 1 | Sep 2022 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Telmisartan & Hydrochlorothiazide Tablets IP | AMT-2460Mfg 2025-11 · Exp 2027-10 | Avalon Medicines Pvt. LtdHaryana | The sample received does not conform to i.p. 2022 specification with respect to the test for Dissolution of hydrochlorothiazide only.Dissolution | CDTL, HyderabadCDSCO lab | Jul 2026 |
| Telmisartan & Hydrochlorothiazide Tablets IP | L-RT25187Mfg 2025-05 · Exp 2027-04 | Rachil Pharma | The sample does not conform to IP with respect to the Test of Dissolution of Hydrochlorothiazide.Dissolution | CDL, KolkataCDSCO lab | Feb 2026 |
| Telmisartan & Hydrochlorothiazide Tablets | L-RT25187Mfg 2025-05 · Exp 2027-04 | Rachil Pharma | Test of Dissolution of HydrochlorothiazideDissolution | CDL, KolkataState lab | Feb 2026 |
| Telmisartan and Hydrochlorothiazide Tablets I.P (40mg/12.5 mg) | TMHT-1012Mfg 2023-09 · Exp 2026-08 | Wings Biotech LLPHimachal Pradesh | Uniformity of weightUniformity of weight/content | State Lab KarnatakaState lab | Jun 2025 |
| Telmisartan and Hydrochlorothiazide Tablets I.P. (40mg/12.5mg) | TMHT1046Mfg 2023-10 · Exp 2026-09 | Wings Biotech LLPHimachal Pradesh | Uniformity of WeightUniformity of weight/content | State Lab KarnatakaState lab | Jun 2025 |
| Telmisartan & Hydrochlorothiazide Tablets IP (Telmijack-H) | T-20560Mfg 2024-03 · Exp 2026-02 | Jackson Laboratories Pvt. Ltd | "Related substances and Assay of Hydrochlorothiazi de"Assay | CDTL MumbaiCDSCO lab | Apr 2025 |
| Telvas H 40/12.5 (Telmisartan & Hydrochlorothiazide Tablets I.P.) | SPB240 306Mfg 2024-02 · Exp 2026-01 | Aristo Pharmaceuticals Pvt. LtdSikkim | Does not conform to I.P.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab | Mar 2025 |
| Telmisartan and Hydrochlorothiazide Tablets IP (Telverge H) | BD231669HMfg 2023-11 · Exp 2025-10 | Bioaltus Pharmaceuticals Pvt. LtdHimachal Pradesh | Dissolution of HydrochlorothiazideDissolution | CDTL HyderabadCDSCO lab | Mar 2024 |
| Telmisartan and Hydrochlorothiazide Tablets IP (SARTAN-H TABLETS) | 12259Mfg 2022-01 · Exp 2023-12 | Biologics IncHimachal Pradesh | Dissolution of TelmisartanDissolution | RDTL ChandigarhState lab | Dec 2022 |
| Losacon-H (Losartan Potassium & Hydrochlorothiazide Tablets I.P.) | C21L262001Mfg 2022-02 · Exp 2024-01 | Concept Pharmaceuticals LtdMaharashtra | Assay of HydrochlorthiazideAssay | CDL KolkataCDSCO lab | Sep 2022 |
| Telmisartan 40 mg and Hydrochlorothiazide 12.5 mg Tablets IP (TELMA H TABLETS) | 20DDT-035Mfg 2020-12 · Exp 2023-11 | Dallas Drugs Pvt. LtdHimachal Pradesh | Assay of TelmisartanAssay | RDTL ChandigarhState lab | Mar 2022 |
| Telmisartan 40 mg and Hydrochlorothiazide 12.5 mg Tablets IP (TELMA H TABLETS) | 18200994Mfg 2020-10 · Exp 2023-09 | Glenmark Pharmaceuticals LtdSikkim | Assay of TelmisartanAssay | RDTL ChandigarhState lab | Feb 2022 |
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.